Drugs / GHB04L1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03745274 | Dec 2008 → May 2009 | avian influenza | AVIR Green Hills Biotechnology AG | Completed | No outcome recorded |
| Phase 1 | NCT00741806 | Aug 2008 → Dec 2009 | influenza | AVIR Green Hills Biotechnology AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GHB04L1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00741806 ↗ |
| Modality | Vaccine | “intranasal vaccination with a single dose of GHB04L1” NCT00741806 ↗ |
| Route | Intranasal | “single dose intranasal administration of GHB04L1” NCT00741806 ↗ |